Keratoacanthoma centrifugum marginatum: Response to topical 5-fluorouracil - 09/08/11
Doi : 10.1016/j.jaad.2005.07.023
Sayuri Yuge, MD a, ⁎ 
, Deise Aparecida Santos Godoy, MD a, ⁎ , Maria Carolina Coelho de Melo, MD a, Danilo Silveira Sousa, MD a, Cleverson Teixeira Soares, MD b
, Deise Aparecida Santos Godoy, MD a, ⁎ , Maria Carolina Coelho de Melo, MD a, Danilo Silveira Sousa, MD a, Cleverson Teixeira Soares, MD b a From the Departments of Dermatology
b Pathology, Instituto Lauro de Souza Lima, São Paulo, Brazil
Correspondence to: Sayuri Yuge, MD, Rodovia Comandante João Ribeiro de Barros km 225/226 Bairro Aimorés, Bauru-SP, Brazil.Reprint requests: Deise Aparecida da Silva Godoy, MD, Rodovia Comandante João Ribeiro de Barros km 225/226 Bairro Aimorés, Bauru-SP, Brazil.São Paulo, Brazil
Abstract |
Keratoacanthoma centrifugum marginatum (KCM) is a rare variant of keratoacanthoma, characterized by progressive peripheral growth with concomitant healing of the central area of the tumor. We present a patient with KCM who was treated with topical 5% 5-fluorouracil. This is the third reported case of KCM treated with this agent.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Supported by Stiefel Laboratories. Presented as a poster at the 59th Meeting of the Brazilian Society of Dermatology, Natal-RN, Brazil, September 25-29, 2004. Funding sources: None. Conflicts of interest: None identified. |
© 2006
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 54 - N° 5S
P. S218-S219 - maggio 2006 Ritorno al numero
Articolo precedente
- Multifocal lymphangioendotheliomatosis with thrombocytopenia
- Jensen Yeung, Gino Somers, Sandra Viero, Elena Pope
- Primary cutaneous paraganglioma of the scalp
- Payam Saadat, Sarka Cesnorek, Ramin Ram, Linda Kelly, Manjunath Vadmal
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?